InvestorsHub Logo
Followers 68
Posts 5584
Boards Moderated 0
Alias Born 01/13/2012

Re: ddls post# 55627

Friday, 10/02/2015 8:20:54 PM

Friday, October 02, 2015 8:20:54 PM

Post# of 329598
So living in the past. It's 2015 and BIEL and other manufacturers are going to get FDA reclassification of their devices as Class II from Class III as 'the' major breakthrough toward approval for sale of the devices here in the US.

Those against the FDA reclassification and emergence of ActiPatch type devices and the eventuality of major reductions in the epidemic consumption of harmful, addictive chemical pain management drugs either still use an abacus, write snail mail letters, use lanterns, rotary dial phones, buses to go from NY to LA, keep travel locally by horse and go to bed when it gets dark, or, have ulterior motives. Not my issue, I am only interested in 2015 and the future of pain management using BIEL type devices instead of harmful drugs. In my opinion, anyone bashing BIEL is endorsing the continuing epidemic use of harmful drugs. There will always be a place for chemical drugs, but never again to the extent that Americans are consuming today. This is being proven now in England where tot OTC sales of ActiPatch are escalating through the roof.

Good luck with all the yesteryear. BIEL is here, it is an American company that miniaturized a scientific innovation that works and the UK was intelligent enough to endorse ActiPatch, Canada too, and it's already helping tens, hundreds of thousands in England to better and more safely manage their pain. Our approval process takes longer, part of the cost of doing business here, but the BIEL/ActiPatch/ALLAY train is coming to Walgreens, CVS, Rite Aid, Walmart and all the rest, soon!